Key result
Elevated soluble LRP1 levels are linked to idiopathic dilated cardiomyopathy compared to healthy controls.
Why the study?
Are circulating levels of soluble LRP1 increased in patients with idiopathic dilated cardiomyopathy, and is it exported via extracellular vesicles?
Case-Control (n=35)
Single-blind
Are circulating levels of soluble LRP1 increased in patients with idiopathic dilated cardiomyopathy, and is it exported via extracellular vesicles?
p-value: p=0.034
Circulating sLRP1 is elevated in idiopathic dilated cardiomyopathy but is not transported via extracellular vesicles, suggesting it may serve as a potential blood biomarker.
sLRP1 may indicate idiopathic dilated cardiomyopathy but should not yet change practice; leaves open non-EV sources in case-control data.
Idiopathic dilated cardiomyopathy (IDCM) is a frequent cause of heart transplantation. Potentially valuable blood markers are being sought, and low-density lipoprotein receptor-related protein 1 (LRP1) has been linked to the underlying molecular basis of the disease. This study compared circulating levels of soluble LRP1 (sLRP1) in IDCM patients and healthy controls and elucidated whether sLRP1 is exported out of the myocardium through extracellular vesicles (EVs) to gain a better understanding of the pathogenesis of the disease. LRP1 α chain expression was analysed in samples collected from the left ventricles of explanted hearts using immunohistochemistry. sLRP1 concentrations were determined in platelet-free plasma by enzyme-linked immunosorbent assay. Plasma-derived EVs were extracted by size-exclusion chromatography (SEC) and characterized by nanoparticle tracking analysis and cryo-transmission electron microscopy. The distributions of vesicular (CD9, CD81) and myocardial (caveolin-3) proteins and LRP1 α chain were assessed in SEC fractions by flow cytometry. LRP1 α chain was preferably localized to blood vessels in IDCM compared to control myocardium. Circulating sLRP1 was increased in IDCM patients. CD9- and CD81-positive fractions enriched with membrane vesicles with the expected size and morphology were isolated from both groups. The LRP1 α chain was not present in these SEC fractions, which were also positive for caveolin-3. The increase in circulating sLRP1 in IDCM patients may be clinically valuable. Although EVs do not contribute to higher sLRP1 levels in IDCM, a comprehensive analysis of EV content would provide further insights into the search for novel blood markers.
No takes yet. Share an insight, caveat, or question.
Roura et al. (2017) conducted a case-control in Idiopathic dilated cardiomyopathy (n=35). Idiopathic dilated cardiomyopathy vs. Healthy controls was evaluated on Circulating levels of soluble LRP1 (sLRP1) (p=0.034). Circulating levels of soluble LRP1 were significantly higher in patients with idiopathic dilated cardiomyopathy compared to healthy controls (P=0.034), though these levels were not associated with plasma-derived extracellular vesicles.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: